Bosulif (bosutinib) 500 mg film-coated tablets, 28 tablets (Pfizer Deutschland GmbH) CML treatment. Drug delivery from Europe and beyond within 4-5 days, storage conditions are met, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Bosulif indications for the treatment of adults:

• for the first time diagnosed with chronic myeloid leukemia (CML) with the presence of the Philadelphia chromosome (Ph+) in the chronic phase;
• chronic myocardial infarction leukemia (CML) with the presence of the Philadelphia chromosome (Ph+) in the chronic phase, acceleration phase or during blast crisis in cases of intolerance or ineffectiveness of advanced therapy.

• Dozuvannya

  Above the diagnosis of Ph+ CML in the chronic phase

  The recommended dose is 400 mg bosutinib once a day.

  Ph+ CML in the chronic phase, acceleration phase or blast crisis due to intolerance or ineffectiveness of advanced therapy

  The recommended dose is 500 mg bosutinib once a day.